- Cat. No.
- A59260
Virodhamine TFA
Virodhamine TFA is an endocannabinoid that targets cannabinoid (CB) receptors, acting as an antagonist of the CB1 receptor while functioning as an agonist for the CB2 receptor. This compound induces megakaryocytic differentiation through the activation of MAPK signaling pathways and the production of reactive oxygen species (ROS). Virodhamine TFA is valuable for research related to neurological disorders, including Alzheimer's and Parkinson's diseases, offering insights into the modulation of neurotransmission and cellular differentiation.